Louis Portugal to Female
This is a "connection" page, showing publications Louis Portugal has written about Female.
Connection Strength
0.134
-
Lingual osseous choristoma. Ear Nose Throat J. 2016 Jul; 95(7):260-1.
Score: 0.028
-
Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 2000 Jan; 22(1):34-41.
Score: 0.009
-
AHNS Series - Do you know your guidelines? Principles of treatment for glottic cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 09; 39(9):1729-1732.
Score: 0.007
-
Laryngotracheal Involvement in Systemic Light Chain Amyloidosis. Head Neck Pathol. 2018 Mar; 12(1):127-130.
Score: 0.007
-
AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 02; 39(2):201-205.
Score: 0.007
-
Long-term follow-up of tracheoesophageal puncture results. Ann Otol Rhinol Laryngol. 1996 Jul; 105(7):501-3.
Score: 0.007
-
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol. 2016 05; 27(5):908-13.
Score: 0.007
-
Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope. 1994 Sep; 104(9):1174-7.
Score: 0.006
-
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41.
Score: 0.006
-
Sclerosing cervicitis: an unusual cause of syncope. Am J Otolaryngol. 1993 Sep-Oct; 14(5):358-62.
Score: 0.006
-
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. Head Neck Oncol. 2011 Jul 26; 3:31.
Score: 0.005
-
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer. 2011 Oct 15; 117(20):4671-8.
Score: 0.005
-
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Ann Oncol. 2011 Nov; 22(11):2501-2507.
Score: 0.005
-
Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope. 2010 Jan; 120(1):93-9.
Score: 0.004
-
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004 Aug; 15(8):1179-86.
Score: 0.003
-
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004 May; 26(5):447-55.
Score: 0.003
-
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5936-43.
Score: 0.003
-
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res. 2003 May; 9(5):1689-97.
Score: 0.003
-
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003 Jan 15; 21(2):320-6.
Score: 0.003
-
Parathyroid adenoma after radioactive iodine therapy for multinodular goiter. Am J Otolaryngol. 2001 Sep-Oct; 22(5):374-5.
Score: 0.002
-
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001 Apr 01; 19(7):1961-9.
Score: 0.002
-
Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density. Head Neck. 1998 Mar; 20(2):152-8.
Score: 0.002
-
Prognostic indicators for squamous cell carcinoma of the oral cavity: a clinicopathologic correlation. Laryngoscope. 1997 Sep; 107(9):1239-44.
Score: 0.002
-
Negative-pressure pulmonary edema in the otolaryngology patient. Otolaryngol Head Neck Surg. 1997 Jul; 117(1):62-6.
Score: 0.002